Literature DB >> 32449389

Decrease in alpha-1 antiproteinase antitrypsin is observed in primary Sjogren's syndrome condition.

Brij B Singh1,2, Joyce Ohm2, Fredice O Quenum Zanbede2, Pooja Chauhan2, Frans G M Kroese3, Arjan Vissink4, Julian L Ambrus5, Bibhuti B Mishra1,2.   

Abstract

Primary Sjogren's syndrome (pSS) is a systemic autoimmune disease that is characterized by the infiltration of immune cells. Although the loss of salivary gland function is a major manifestation observed in pSS, the factors that could promote these changes in salivary gland tissue in pSS is not yet determined. Herein, we provide evidence that loss of alpha-1 antiproteinase antitrypsin could contribute to the induction of pSS. Alpha-1 antiproteinase antitrypsin belongs to the family of serpin proteins that function as protease inhibitors and protect secretory cells against proteases, especially to elastases that is secreted from lymphocytes. Importantly, expression of alpha-1 antiproteinase antitrypsin was decreased (more than 3-fold), along with an increase in elastase expression, in pSS samples when compared with age-matched non-SS-SICCA patients. Consistent with the human data, loss of alpha-1 antiproteinase antitrypsin, as well as an increase in immune infiltration, was observed in IL14α transgenic mice that exhibit SS like symptoms. Moreover, an age-dependent increase in elastase expression was observed in IL14α transgenic mice along with a decrease in total saliva secretion. Importantly, a 4-fold increase in microRNA132 expression, but not in other microRNAs, and increased DNA methylation in the promoter/noncoding region of serpina gene was observed in pSS, which could be responsible for the inhibition of alpha-1 antiproteinase antitrypsin expression in salivary gland cells of pSS patients. Together, these findings demonstrate that epigenetic regulations that include DNA methylation and microRNAs that could modulate the expression of alpha-1 antiproteinase antitrypsin in salivary glands and could be involved in the onset of pSS.

Entities:  

Keywords:  DNA methylation; Sjogren’s syndrome; alpha-1 antiproteinase antitrypsin; microRNAs; salivary glands

Mesh:

Substances:

Year:  2020        PMID: 32449389      PMCID: PMC7802062          DOI: 10.1080/08916934.2020.1768376

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  48 in total

Review 1.  Clinical manifestations and early diagnosis of Sjögren syndrome.

Authors:  Stuart S Kassan; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2004-06-28

2.  Health-related quality of life, employment and disability in patients with Sjogren's syndrome.

Authors:  Jiska M Meijer; Petra M Meiners; James J R Huddleston Slater; Fred K L Spijkervet; Cees G M Kallenberg; Arjan Vissink; Hendrika Bootsma
Journal:  Rheumatology (Oxford)       Date:  2009-06-24       Impact factor: 7.580

3.  ATP-dependent activation of K(Ca) and ROMK-type K(ATP) channels in human submandibular gland ductal cells.

Authors:  X Liu; B B Singh; I S Ambudkar
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

4.  Tolerance without toxicity? α1-antitrypsin as a novel alternative to immunosuppression.

Authors:  Steven Goldstein; Pavan Reddy
Journal:  Expert Rev Clin Immunol       Date:  2012-07       Impact factor: 4.473

Review 5.  Inflammation in Sjögren's syndrome: Cause or consequence?

Authors:  Ana Raquel Rodrigues; Raquel Soares
Journal:  Autoimmunity       Date:  2017-02-14       Impact factor: 2.815

Review 6.  Sjögren's syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  Annu Rev Pathol       Date:  2013-09-18       Impact factor: 23.472

Review 7.  Primary Sjögren's Syndrome.

Authors:  Xavier Mariette; Lindsey A Criswell
Journal:  N Engl J Med       Date:  2018-03-08       Impact factor: 91.245

8.  Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects.

Authors:  A Churg; J Dai; K Zay; A Karsan; R Hendricks; C Yee; R Martin; R MacKenzie; C Xie; L Zhang; S Shapiro; J L Wright
Journal:  Lab Invest       Date:  2001-08       Impact factor: 5.662

Review 9.  Epigenetic alterations underlying autoimmune diseases.

Authors:  Saeed Aslani; Mahdi Mahmoudi; Jafar Karami; Ahmad Reza Jamshidi; Zahra Malekshahi; Mohammad Hossein Nicknam
Journal:  Autoimmunity       Date:  2016-01-13       Impact factor: 2.815

Review 10.  Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.

Authors:  Markus Huber-Lang; Kristina N Ekdahl; Rebecca Wiegner; Karin Fromell; Bo Nilsson
Journal:  Semin Immunopathol       Date:  2017-09-12       Impact factor: 9.623

View more
  1 in total

Review 1.  A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application.

Authors:  Michael E O'Brien; Grace Murray; Debananda Gogoi; Azeez Yusuf; Cormac McCarthy; Mark R Wormald; Michelle Casey; Claudie Gabillard-Lefort; Noel G McElvaney; Emer P Reeves
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.